Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Laboratories turned to a smart workaround when COVID‑19 testing kits became scarce in 2020. They mixed samples from several ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

With the “gym,” Insilico is now targeting other biotech and pharmaceutical companies, offering to train new AI models for ...

Many natural compounds that act on the human body provide active ingredients for medicines or clues for developing them, and ...

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...

Nvidia and Eli Lilly and Co. are partnering to create an artificial intelligence lab in the San Francisco Bay Area to ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

AI chipmaker Nvidia (NVDA) and pharmaceutical giant Eli Lilly (LLY) on Monday announced that the two companies would jointly ...